Skip to content

Effect of Complimentary Yoga therapy on chronic indigestion

Effect of adjuvant Yoga Therapy on nonulcer dyspepsia among patients in a tertiary care hospital: A randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021773
Enrollment
152
Registered
2019-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

Intervention1: Yoga Therapy: Yoga Therapy protocol will be given to subjects in experimental group along with standard medical management. The participants will receive guided session once a week and

Sponsors

UGCNET Junior Research Fellowship
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with typical symptoms of non-ulcer dyspepsia like epigastric pain, post prandial fullness, early satiety, burning sensation, bloating, belching, nausea/vomiting for more than 3 months with onset at least 6 months previously (H.Pylori positive/negative). 2) Able to perform techniques in the protocol. 3) Willing to participate in Yoga therapy.

Exclusion criteria

Exclusion criteria: Patients with Peptic Ulcer Disease (PUD), gastro-oesophageal reflux disease (GERD), gastric carcinomas, hematemesis, hiatal hernia, congenital malformations, liver disease, history of recent surgery within 6 months, heart disease, hypertension, epilepsy, bleeding piles.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Yogic practices on 1) Major symptoms of dyspepsia including epigastric pain, burning, bloating, belching, nausea and vomiting (GSRS and Dyspepsia Questionnaire). 2) Clearance of H.Pylori bacteria in the H.Pylori positive dyspeptic patients group (H.Pylori stool antigen test). 3) Psychological parameters like stress, anxiety and depression in dyspepsia patients (PSS, GAD-7 and PHQ-9). Timepoint: Evaluation will be done before and after 3 months for each patient.

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Ananda Balayogi Bhavanani

CYTER, SBV

yoga@mgmcri.ac.in9842311433

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026